Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Hyperuricemia is not infrequently encountered among hemodialysis patients. However, there is
no clear data about use of febuxostat among hemodialysis patients, apart from very small case
series. The aim of this study is to investigate the efficacy of using febuxostat for the
treatment of Hyperuricemia among hemodialysis patients.